Submissions are open for the upcoming issue.

Molecular Medicine Peer-reviewed scientific journal

Found: 17

ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2026 · pp. 3–8

Molecular mechanisms of astrocyte involvement in the pathogenesis of Parkinson’s disease

Introduction. Parkinson’s disease (PD) is a chronic, progressive neurodegenerative disorder, the primary pathological feature of which is the death of dopaminergic neurons in the substantia nigra pars compacta and the accumulation of aggregated α-synuclein. Th…

10.29296/24999490-2026-03-01Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2025 · pp. 48–55

Molecular mechanisms of skin biorevitalization: expression of signaling molecules under the action of trehalose-containing gel

Introduction: Biorevitalization is a modern method of injection cosmetology aimed at correcting age-related skin changes by introducing hyaluronic acid (HA) and additional biologically active components. The hyaluronic gel for microimplantation and mesotherapy…

10.29296/24999490-2025-03-06Details ↗
ОБЗОР2025 · pp. 16–26

Neurodegenerative diseases as a target for genome editing: from preclinical studies to clinical practice

Objective. To analyze the current state of preclinical and clinical studies in genome editing for neurodegenerative diseases, evaluate its potential impact on clinical practice, and examine ethical aspects of these technologies’ application. Material and metho…

10.29296/24999490-2025-01-02Details ↗
ОБЗОР2024 · pp. 29–39

Innovative approaches to genome editing in the treatment of neurodegenerative diseases

The purpose of this review is to analyze current advances in the field of genome editing, their application for the modeling and treatment of neurodegenerative diseases, as well as to discuss current limitations and prospects for overcoming barriers in clinica…

10.29296/24999490-2024-06-04Details ↗
ОБЗОР2024 · pp. 16–22

Biomarkers of oxidative stress and proteopathies in the diagnosis of neurodegenerative diseases

Introduction. Despite numerous studies in the field of neurodegenerative diseases, the exact mechanisms of these processes have not yet been identified. The purpose of this review is to analyze the methodological approaches necessary to revise the traditional …

10.29296/24999490-2024-02-03Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2024 · pp. 43–51

Mitochondrial proteins as biomarkers of occupational disease risk of pilots and astronauts

Introduction. Mitochondrial dysfunction is an important pathogenic mechanism of neurodegeneration, characterized by a progressive structural and functional loss of neurons, leading to heterogeneous clinical and pathological manifestations with subsequent impai…

10.29296/24999490-2024-01-06Details ↗
ОБЗОР2022 · pp. 18–27

FIBROBLAST GROWTH FACTORS AND THEIR EFFECT ON COGNITIVE FUNCTIONS AND THE COURSE OF CENTRAL NERVOUS SYSTEM DEGENERATIVE DISEASES

Aim of investigation. The study of characteristics of fibroblast growth factors (FGFs), as a man factor FGFd, including 22 structurally connected polypeptides, is necessary for the neuroprotection by the CNS degenerative pathology is presented playing a great …

10.29296/24999490-2022-05-03Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2022

MITOCHONDRIA – INTRACELLULAR TARGETS OF GEROPROTECTIVE EFFECT OF V007

Introduction. Oxidative stress and mitochondrial dysfunction are observed in virtually any disease associated with premature aging. Signaling molecules produced by mitochondria can act as specific targets for the action of pharmacological agents in order to re…

10.29296/24999490-2022-01-04Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2021

MITOCHONDRIA PROTEINS OF CARDIOMYOCYTES AS MOLECULAR TARGETS OF THE PREPARATION V007

Introduction. Mitochondria are one of the most important cellular organelles that provide cells with energy, take part in cellular renewal and the implementation of endogenous mechanisms of cellular immunity. The study of the structural and functional organiza…

10.29296/24999490-2021-06-05Details ↗
ОБЗОР2020

NEURODEGENERATIVE DISEASES AND BIOMEDICAL CELL PRODUCTS: RELEVANCE, DIRECTIONS, AND PROBLEMS OF DEVELOPMENT

Progress in clinical research and medicine has contributed to a significant reduction in the worldwide mortality rate. Currently, the strategy of developed countries is directed at increasing expectancy and improving life quality. As a consequence, the modern …

10.29296/24999490-2020-04-02Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2018

Α-SYNUCLEIN AND AΒ42 PEPTIDE EXPRESSION IN SUBSTANTIA NIGRA AND BUCCAL EPITHELIUM IN PARKINSON DISEASE PATIENTS OF THE DIFFERENT AGE

Introduction. The current direction of modern medicine is the development of new methods for non-invasive diagnosis of neurodegenerative diseases, in particular, Parkinson's disease. The goal of the investigation was the comparative analysis of α-synuclein and…

10.29296/24999490-2018-06-06Details ↗
ОБЗОР2018

GENE THERAPY OF PARKINSON`S DISEASE

Modern methods of treatment of Parkinson's disease (PD) remain to be unsuccessful in cessation of the progression of neurodegenerative processes in the brain. The role of certain genes is proven by the etiology of PD, 10–15% of cases represent a monogenic dise…

10.29296/24999490-2018-01-03Details ↗
ПЕРЕДОВАЯ СТАТЬЯ2018

PHARMACOLOGICAL TREATMENT OF PARKINSON’S DISEASE: MOLECULAR ASPECTS AND PROSPECTS

Parkinson’s disease (PD) is a progressive, age-related, neuronal disorder that affects as much as 1% of the persons over 65 years. According to forecasts of the World Health Organization over the world about 9 million people will suffer from PD by 2030. So PD …

10.29296/24999490-2018-02-01Details ↗
ОБЗОР2016

PHARMACOGENETIC ASPECTS OF THE EFFICACY AND SAFETY OF HALOPERIDOL IN PATIENTS WITH ADDICTIVE DISORDERS

The use of haloperidol in clinical practice is often accompanied by the development of severe unwanted adverse side effects from the side of various organs and systems. In the narcological practice the use of antipsychotic drugs is not seldom complicated by ex…

Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ

MITOCHONDRIA – INTRACELLULAR TARGETS OF GEROPROTECTIVE EFFECT OF V007

Introduction. Oxidative stress and mitochondrial dysfunction are observed in virtually any disease associated with premature aging. Signaling molecules produced by mitochondria can act as specific targets for the action of pharmacological agents in order to re…

10.29296/24999490-2022-01-04Details ↗

Article search and quick navigation

Navigation